相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo
Stephen F. Little et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis
Parul Kulshreshtha et al.
MOLECULAR IMMUNOLOGY (2011)
Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule
Zhaochun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?
Sabina A. Antoniu
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers
Geoffrey K. Feld et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex
Mazdak Radjainia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sequential B-Cell Epitopes of Bacillus anthracis Lethal Factor Bind Lethal Toxin-Neutralizing Antibodies
Melissa L. Nguyen et al.
INFECTION AND IMMUNITY (2009)
Novel Chimpanzee/Human Monoclonal Antibodies That Neutralize Anthrax Lethal Factor, and Evidence for Possible Synergy with Anti-Protective Antigen Antibody
Zhaochun Chen et al.
INFECTION AND IMMUNITY (2009)
Neutralizing Monoclonal Antibodies Directed against Defined Linear Epitopes on Domain 4 of Anthrax Protective Antigen
Cassandra D. Kelly-Cirino et al.
INFECTION AND IMMUNITY (2009)
The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes
Alexander F. Kintzer et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Raxibacumab for the Treatment of Inhalational Anthrax.
Thi-Sau Migone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding
Zhaochun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Selection and characterization of human antibodies neutralizing Bacillus anthracis toxin
Bin Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain
Sharad P. Adekar et al.
PLOS ONE (2008)
Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax
Mark T. Albrecht et al.
INFECTION AND IMMUNITY (2007)
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation
Thibaut Pelat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis ames strain from the lungs in a rabbit model
Johnny W. Peterson et al.
INFECTION AND IMMUNITY (2007)
Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen
Sebastian C. J. Steiniger et al.
MOLECULAR IMMUNOLOGY (2007)
Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule
Thomas R. Kozel et al.
INFECTION AND IMMUNITY (2007)
Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity
Laura Vitale et al.
INFECTION AND IMMUNITY (2006)
Past, imminent and future human medical countermeasures for anthrax
L. W. J. Baillie
JOURNAL OF APPLIED MICROBIOLOGY (2006)
A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1
Johanna Rivera et al.
INFECTION AND IMMUNITY (2006)
Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen
ZC Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen
RA Melnyk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A model of anthrax toxin lethal factor bound to protective antigen
DB Lacy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin
NK Lim et al.
INFECTION AND IMMUNITY (2005)
Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694
E Laffly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge
N Mohamed et al.
INFECTION AND IMMUNITY (2005)
Interaction of the 20 kDa and 63 kDa fragments of anthrax protective antigen: Kinetics and thermodynamics
KA Christensen et al.
BIOCHEMISTRY (2005)
Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax
M Drysdale et al.
EMBO JOURNAL (2005)
Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: An anthrax toxin receptor
DB Lacy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Induction of opsonic antibodies to the γ-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate
TT Wang et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia
TR Kozel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Evaluation of penicillin-based inhibitors of the class A and B β-lactamases from Bacillus anthracis
Z Beharry et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Structure of heptameric protective antigen bound to an anthrax toxin receptor: A role for receptor in pH-dependent pore formation
DB Lacy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Binary bacterial toxins:: Biochemistry, biology, and applications of common Clostridium and Bacillus proteins
H Barth et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway
L Abrami et al.
JOURNAL OF CELL BIOLOGY (2004)
Crystal structure of a complex between anthrax toxin and its host cell receptor
E Santelli et al.
NATURE (2004)
US food and drug administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax
A Meyerhoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Selection of Bacillus anthracis isolates resistant to antibiotics
A Athamna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
β-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain
YH Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies
F Brossier et al.
INFECTION AND IMMUNITY (2004)
Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages
N Mohamed et al.
INFECTION AND IMMUNITY (2004)
Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen
DJ Wigelsworth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Binding of anthrax toxin to its receptor is similar to α integrin-ligand interactions
KA Bradley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody
MJ Rosovitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin
LB Price et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor
HM Scobie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process
L Abrami et al.
JOURNAL OF CELL BIOLOGY (2003)
Human antibodies from immunized donors are protective against anthrax toxin in vivo
MA Wild et al.
NATURE BIOTECHNOLOGY (2003)
Antibody-dependent enhancement of virus infection and disease
SMC Tirado et al.
VIRAL IMMUNOLOGY (2003)
Anthrax toxin
RJ Collier et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2003)
Antimicrobial postexposure prophylaxis for anthrax: Adverse events and adherence
CW Shepard et al.
EMERGING INFECTIOUS DISEASES (2002)
Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen
K Cunningham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Anthrax as a biological weapon, 2002 - Updated recommendations for management
TV Inglesby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Mapping the anthrax protective antigen binding site on the lethal and edema factors
DB Lacy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin
CL Drum et al.
NATURE (2002)
Identification of the cellular receptor for anthrax toxin
KA Bradley et al.
NATURE (2001)
Crystal structure of the anthrax lethal factor
AD Pannifer et al.
NATURE (2001)
Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen
P Kumar et al.
INFECTION AND IMMUNITY (2001)
Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein
BM Price et al.
INFECTION AND IMMUNITY (2001)
Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin
J Mogridge et al.
JOURNAL OF BACTERIOLOGY (2001)
A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen
JL Elliott et al.
BIOCHEMISTRY (2000)
In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne
CH Choe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
